| |
| |
|
| Insider
Information: |
Clark Ian T |
| Relationship: |
Director |
| City: |
So San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
18,450 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$245,849 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
18,450 |
|
|
| Total
Value |
$245,849 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
9
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
4
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.3
|
| Percentage
Gain/Loss : |
0.0%
|
 42.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Dendreon Corp |
DNDN |
Director |
2010-08-20 |
0 |
2009-10-07 |
0 |
Premium* |
|
|
TerraVia Holdings Inc |
TVIA |
Director |
2011-06-02 |
3,000 |
2011-06-02 |
0 |
Premium* |
|
|
Kite Pharma, Inc. |
KITE |
Director |
2017-10-03 |
0 |
2017-01-03 |
0 |
Premium* |
|
|
Guardant Health, Inc. |
GH |
Director |
2023-06-14 |
8,901 |
2019-04-15 |
0 |
Premium* |
|
|
Agios Pharmaceuticals Inc |
AGIO |
Director |
2022-05-20 |
6,549 |
2019-05-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
92 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GH |
Guardant Health, Inc. |
Director |
– • – |
2020-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
3,341 |
4,643 |
0 |
- |
|
| DNDN |
Dendreon Corp |
Board of Director |
– • – |
2010-01-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,750 |
8,744 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Director |
– • – |
2017-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
4,690 |
4,690 |
0 |
- |
|
| DNDN |
Dendreon Corp |
Board of Director |
– • – |
2009-10-07 |
4 |
A |
$0.00 |
$0 |
D/D |
4,994 |
4,994 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Director |
– • – |
2017-10-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,324) |
0 |
0 |
- |
|
| GH |
Guardant Health, Inc. |
Director |
– • – |
2021-06-29 |
4 |
OE |
$4.18 |
$377,613 |
D/D |
5,916 |
10,559 |
0 |
- |
|
| GH |
Guardant Health, Inc. |
Director |
– • – |
2023-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,703 |
8,901 |
0 |
- |
|
| DNDN |
Dendreon Corp |
Board of Director |
– • – |
2010-08-20 |
4 |
OE |
$26.64 |
$199,800 |
D/D |
7,500 |
7,500 |
0 |
- |
|
| DNDN |
Dendreon Corp |
Board of Director |
– • – |
2010-08-20 |
4 |
S |
$37.46 |
$280,967 |
D/D |
(7,500) |
0 |
0 |
- |
|
| DNDN |
Dendreon Corp |
Board of Director |
– • – |
2010-05-03 |
4 |
S |
$54.61 |
$477,510 |
D/D |
(8,744) |
0 |
0 |
- |
|
| GH |
Guardant Health, Inc. |
Director |
– • – |
2020-09-08 |
4 |
AS |
$88.69 |
$816,247 |
D/D |
(9,146) |
4,643 |
0 |
- |
|
| GH |
Guardant Health, Inc. |
Director |
– • – |
2020-09-08 |
4 |
OE |
$4.18 |
$38,230 |
D/D |
9,146 |
13,789 |
0 |
- |
|
| GH |
Guardant Health, Inc. |
Director |
– • – |
2019-08-06 |
4 |
AS |
$88.30 |
$869,080 |
D/D |
(9,683) |
1,302 |
0 |
- |
|
| GH |
Guardant Health, Inc. |
Director |
– • – |
2019-08-06 |
4 |
OE |
$4.18 |
$40,475 |
D/D |
9,683 |
10,985 |
0 |
- |
|
| GH |
Guardant Health, Inc. |
Director |
– • – |
2021-06-29 |
4 |
AS |
$130.00 |
$1,372,670 |
D/D |
(10,559) |
0 |
0 |
- |
|
| GH |
Guardant Health, Inc. |
Director |
– • – |
2019-04-15 |
4 |
AS |
$73.90 |
$6,042,951 |
D/D |
(81,772) |
0 |
0 |
- |
|
| GH |
Guardant Health, Inc. |
Director |
– • – |
2019-04-15 |
4 |
OE |
$4.18 |
$341,807 |
D/D |
81,772 |
81,722 |
0 |
- |
|
92 Records found
|
|
Page 4 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
